- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07620886
Effects of Postprandial Walking and Resistance Snacking on Glucose Responses in Adults With Metabolic Syndrome (BITE)
Effects of Postprandial Walking and Brief Resistance Exercise Snacks on Continuous Glucose and Heart Rate Variability Responses in Adults With Metabolic Syndrome and Prediabetes: A Randomized Crossover Trial
This study will examine whether light physical activity after meals can improve 24-hour glucose responses in adults with metabolic syndrome and prediabetes.
Participants will complete three experimental conditions in a randomized crossover order: prolonged sitting, 15 minutes of postprandial walking, and brief resistance exercise snacks consisting of squats and calf raises performed every 20 minutes during the postprandial period. Continuous glucose monitoring will be used to assess 24-hour glucose responses, and heart rate variability will be measured during the 2-hour postprandial period to evaluate acute autonomic responses.
The main outcome is 24-hour mean glucose derived from continuous glucose monitoring.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Metabolic syndrome and prediabetes are associated with impaired glucose regulation and increased cardiometabolic risk. Light physical activity after meals may help reduce postprandial glucose excursions and improve overall daily glucose control. However, it remains unclear whether brief resistance exercise snacks can provide glucose benefits comparable to postprandial walking under standardized meal conditions.
This study is a randomized crossover trial in adults aged 40 to 65 years with metabolic syndrome and prediabetes. Each participant will complete three experimental conditions in a randomized order: prolonged sitting, 15 minutes of walking after a standardized meal, and brief resistance exercise snacks performed every 20 minutes during the postprandial period. The resistance exercise snacks will consist of simple body-weight exercises, including squats and calf raises.
Glucose responses will be assessed using continuous glucose monitoring. The primary outcome will be 24-hour mean glucose after each experimental condition. Key secondary glycemic outcomes will include 2-hour postprandial glucose incremental area under the curve, 2-hour mean glucose, peak glucose, time to peak glucose, nocturnal mean glucose, and glycemic variability indices. Heart rate variability will be assessed during the 2-hour postprandial period using RR interval data collected with a chest strap heart rate monitor to evaluate acute autonomic responses to each condition.
The purpose of this study is to determine whether brief resistance exercise snacks can improve 24-hour glucose regulation and postprandial glucose responses compared with uninterrupted sitting, and whether these responses are comparable to postprandial walking.
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Yunmin Han
- Telefonnummer: +82-10-3537-2339
- E-mail: hym224@snu.ac.kr
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Beskrivelse
Inclusion Criteria:
- Inclusion Criteria:
- Adults aged 40 to 65 years
- Presence of metabolic syndrome
- Fasting glucose of 100 mg/dL or higher or HbA1c of 5.7% or higher
- Not regularly engaged in structured exercise training, defined as less than 150 minutes per week during the past year
- Able to consume the standardized study meals
- Able to wear a continuous glucose monitor and a chest strap heart rate monitor
- Able to provide written informed consent
Exclusion Criteria:
- History of major cardiovascular, cerebrovascular, respiratory, renal, hepatic, neurological, or other severe medical conditions that may affect study participation.
- Uncontrolled hypertension, defined as systolic blood pressure ≥160 mmHg or diastolic blood pressure ≥100 mmHg.
- Current use of medications associated with a high risk of hypoglycemia, such as insulin or sulfonylureas.
- Initiation or dose change of insulin or oral glucose-lowering medications within the past 3 months.
- Initiation or dose change of medications for hypertension, dyslipidemia, or diabetes within the past 3 months.
- Musculoskeletal, neurological, or orthopedic conditions that limit safe participation in walking or body-weight resistance exercise, including severe knee, hip, back, or ankle pain.
- Regular participation in moderate-to-vigorous exercise of 150 minutes or more per week during the past year.
- Difficulty consuming the standardized study meals, including food allergy, dietary restrictions, or severe gastrointestinal symptoms.
- Difficulty wearing a continuous glucose monitor or history of severe skin irritation or allergy to adhesive sensors.
- Difficulty wearing a chest strap heart rate monitor or skin problems at the chest strap site.
- Pregnancy or planned pregnancy.
- Acute illness, infection, surgery, or hospitalization within the past month.
- Current participation in another interventional study.
- Any condition judged by the investigator to make participation unsafe or inappropriate.
Exclusion Criteria:
-
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Forebyggelse
- Tildeling: Randomiseret
- Interventionel model: Crossover opgave
- Maskning: Dobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Ingen indgriben: Prolonged Sitting
Participants will remain seated during the 2-hour postprandial period after consuming a standardized meal.
|
|
|
Eksperimentel: Postprandial Walking
Participants will perform 15 minutes of light-to-moderate walking after consuming a standardized meal.
|
Participants will perform 15 minutes of light-to-moderate walking after consuming a standardized meal.
Walking intensity will be monitored using heart rate and rating of perceived exertion.
|
|
Eksperimentel: Brief Resistance Exercise Snacks
Participants will perform 3-minute bouts of body-weight resistance exercises, including squats and calf raises, every 20 minutes during the postprandial period after consuming a standardized meal.
|
Participants will perform 3-minute bouts of body-weight resistance exercises every 20 minutes during the postprandial period after consuming a standardized meal.
The exercise bouts will include squats and calf raises.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
24-hour mean glucose
Tidsramme: 24 hours after each experimental condition
|
Mean glucose over 24 hours after each experimental condition, derived from continuous glucose monitoring.
|
24 hours after each experimental condition
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
2-hour postprandial glucose incremental area under the curve
Tidsramme: 0 to 120 minutes after the standardized meal
|
The 2-hour postprandial glucose incremental area under the curve will be calculated from continuous glucose monitoring data after the standardized meal.
|
0 to 120 minutes after the standardized meal
|
|
Change in RMSSD
Tidsramme: 0 to 120 minutes after the standardized meal
|
Change in the root mean square of successive differences from the pre-meal resting baseline during the 2-hour postprandial period.
RMSSD will be calculated from RR interval data collected with a chest strap heart rate monitor.
|
0 to 120 minutes after the standardized meal
|
Samarbejdspartnere og efterforskere
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- SNU-CGM-EX-2026
- 2601/001-020 (Anden identifikator: Seoul National University Institutional Review Board approval number)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Metabolisk syndrom
-
Consorcio Centro de Investigación Biomédica en...Hospital General Universitario Gregorio Marañon; Universidad Complutense... og andre samarbejdspartnereIkke rekrutterer endnuLeverfibrose/NASH | MASH - Metabolic Dysfunction-Associated Steatohepatitis | MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseSpanien
-
Rivus Pharmaceuticals, Inc.RekrutteringMASH - Metabolic Dysfunction-Associated SteatohepatitisForenede Stater
-
Madrigal Pharmaceuticals, Inc.RekrutteringMASH - Metabolic Dysfunction-Associated SteatohepatitisForenede Stater
-
Shanghai East HospitalRekrutteringMASH - Metabolic Dysfunction-Associated SteatohepatitisKina
-
Southern California Institute for Research and...Ikke rekrutterer endnuMASH - Metabolic Dysfunction-Associated Steatohepatitis
-
Nabiqasim Industries (Pvt) LtdRekrutteringMASH - Metabolic Dysfunction-Associated SteatohepatitisPakistan
-
Fondazione Policlinico Universitario Agostino Gemelli...RekrutteringMASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseItalien
-
Tangram Therapeutics PlcRekrutteringSunde deltagere | MASH - Metabolic Dysfunction-Associated SteatohepatitisDet Forenede Kongerige
-
University of Campania Luigi VanvitelliAfsluttetMASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseItalien
-
University Hospital, Basel, SwitzerlandIkke rekrutterer endnuKardiovaskulær-Kidney-metabolsk syndrom | Cradiovascular-Kidney-Liver-Metabolic (CKLM) syndromSchweiz
Kliniske forsøg med Postprandial walking
-
Women and Infants Hospital of Rhode IslandRekrutteringGraviditetskomplikationer | Svangerskabsdiabetes | Fostermakrosomi | Graviditet hos diabetikereForenede Stater
-
State University of New York at BuffaloAfsluttet
-
Universidad de ExtremaduraMinistry of Science and Innovation, SpainAfsluttetInsulin | Ghrelin | Glukose | GLP-1 Koncentration | Mæthed, Mæthed | Kalorieindtag | Leptin niveauerSpanien
-
Leonardo A. Peyré-TartarugaAline Nogueira Haas; Flávia Gomes MartinezIkke rekrutterer endnuMultipel sclerose | Multipel sklerose, kronisk progressiv | Multipel sklerose, sekundær progressiv | Multipel sklerose, primær progressivBrasilien
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Afsluttet
-
University of Alabama at BirminghamAfsluttetNeuropatisk smerte | RygmarvsskaderForenede Stater
-
Riphah International UniversityAfsluttet
-
Institut National de Recherche pour l'Agriculture...RekrutteringIkke-afhængige 60 til 75-årige mænd og kvinderFrankrig
-
University of ExeterAfsluttetSund og raskDet Forenede Kongerige